July 1 saw the launch of adult-use cannabis sales in Maryland, making it the 21st state to legalise recreational cannabis in the country.
A number of existing medical cannabis dispensaries have now converted their license in order to be able to serve adult use customers. However, to ensure patient’s are still able to access their medicine the new laws will see the introduction of patient-only operating hours or dedicated service lines for patients, as well a dedicated product availability.
Last week, in advance of the incoming laws, Governor Wes Moore addressed the Cannabis Regulators Association’s annual conference, emphasising the state’s commitment to promoting social equity and restorative justice in the new market.
Speaking at the conference, Moore stated: “In the past, cannabis policy has been used as a cudgel to oppress, jail, and discriminate against our fellow citizens, especially people of color; and the war on drugs didn’t just fail, it made us weaker as a nation.
READ MORE: Adult Use Cannabis Sales to Begin in Maryland July 1
“But now, we are writing a new chapter in the story of cannabis in America — a chapter focused on equity and economic growth. It’s time we moved away from this false choice that says we must pick an economy that is equitable or an economy that is growing — we can, and we will, do both.”
Jesse Channon, Chief Growth Officer, Columbia Care, which began sales in three Maryland retail locations on July 1, stated: “The start of adult use sales in Maryland is a truly momentous occasion for our customers and for the industry as a whole.
“We continue to see some states taking immediate action on ballot initiatives across the country and working diligently to put a framework together to build a broader, safer and more inclusive cannabis marketplace with the introduction of adult use sales.
“This swift action, and inclusion of existing operators who understand the landscape, shows a commitment from state leaders to help connect the power of the cannabis plant to those who need and want it.
“We are proud to be a part of the initial adult use framework and look forward to continuing to serve the medical community as we have for years.”
